Clinical Trial Update: Radiofrequency Ablation for Gastric Metaplasia and Dysplasia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated radiofrequency ablation for gastric dysplasia and intestinal metaplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Dysplasia
• Intestinal Metaplasia

Snippet

Sponsor: The University of Hong Kong | Conditions: Gastric Dysplasia, Intestinal Metaplasia | Phase 1, Phase 2 | Status: COMPLETED